Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sonlicromanol in Post-COVID
NCT07298005Phase 2Recruiting
- Start
- Apr 2026
- Primary completion
- Feb 2027
- Countries
- 1
01
Overview
A Phase 2 trial of sonlicromanol in post-COVID-19 condition (PCC). Started Apr 2026; status: recruiting.
02
Drugs
sonlicromanol
03
Conditions
post-COVID-19 condition (PCC)
Beyond the preview
Go deeper on NCT07298005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07298005.